Pfizer begins mid-stage trial for new vaccine targeting Omicron subvariant

Pfizer said the new vaccine, which targets both the original as well as the BA.2 Omicron subvariant, is in an initial proof-of-concept study to gather more data

Source: Pfizer begins mid-stage trial for new vaccine targeting Omicron subvariant

Category: Health, World, BA.2 Omicron Subvariant, COVID, COVID-19, COVID-19 Vaccine, Omicron, omicron covid symptoms, omicron vaccine, Pfizer, Vaccine